Share on StockTwits

T2 Biosystems (NASDAQ:TTOO) COO Sarah O. Kalil acquired 15,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 12th. The shares were purchased at an average price of $11.00 per share, for a total transaction of $165,000.00. Following the acquisition, the chief operating officer now directly owns 15,000 shares in the company, valued at approximately $165,000. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

T2 Biosystems (NASDAQ:TTOO) opened at 17.00 on Monday. T2 Biosystems has a 52 week low of $13.40 and a 52 week high of $17.374. The stock’s 50-day moving average is $15.37 and its 200-day moving average is $15.37. The company’s market cap is $326.3 million.

T2 Biosystems, Inc is an in vitro diagnostics company. The Company that has developed a technology platform that offers a rapid, sensitive and simple alternative to existing diagnostic methodologies.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.